Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3S43

HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2008-03-18
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)0.8
Spacegroup nameP 21 21 2
Unit cell lengths58.374, 86.565, 46.306
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution10.000 - 1.260
R-factor0.1602
Rwork0.160
R-free0.20020
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)3djk
RMSD bond length0.013
RMSD bond angle0.031
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareAMoRE
Refinement softwareSHELXL-97
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.310
High resolution limit [Å]1.2601.260
Rmerge0.0630.361
Number of reflections58771
<I/σ(I)>14.52.1
Completeness [%]91.359.9
Redundancy3.72
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP5.4298FROM A 3.5MG/ML PROTEIN SOLUTION AT PH 5.4 WITH 0.175M KI, 0.1M CITRATE PHOSPHATE, 4% DMSO. 1.0ul WELL SOLUTION WITH 1.5ul PROTEIN SOLUTION. THE INHIBITOR WAS MIXED WITH PROTEASE IN A RATIO 5:1, EVAPORATION, TEMPERATURE 298K, VAPOR DIFFUSION, HANGING DROP

224201

PDB entries from 2024-08-28

PDB statisticsPDBj update infoContact PDBjnumon